| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14728214.6.2.249 |
| P698 | PubMed publication ID | 15989525 |
| P2093 | author name string | Wallace MS | |
| P2860 | cites work | Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice | Q28334553 |
| A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons | Q28570486 | ||
| Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial | Q29029237 | ||
| Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. | Q31431825 | ||
| Effect of mexiletine on spinal cord injury dysesthetic pain. | Q54217676 | ||
| Characterization of two kinds of high-voltage-activated Ca-channel currents in chick sensory neurons. Differential sensitivity to dihydropyridines and omega-conotoxin GVIA. | Q54352861 | ||
| Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial | Q57984131 | ||
| 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial | Q33743755 | ||
| Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia | Q33848766 | ||
| Hyperalgesia due to nerve injury: role of prostaglandins | Q33882003 | ||
| Exocytotic Ca2+ channels in mammalian central neurons | Q34293789 | ||
| A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
| Spinal pharmacology of tactile allodynia in diabetic rats | Q35026970 | ||
| Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent | Q35027706 | ||
| The Central Role of Voltage-Activated and Receptor-Operated Calcium Channels in Neuronal Cells | Q35229123 | ||
| Calcium channels in vertebrate cells | Q37876260 | ||
| Calcium action in synaptic transmitter release | Q38173587 | ||
| Classes of calcium channels in vertebrate cells | Q38269272 | ||
| The use of lamotrigine in neuropathic pain | Q39443944 | ||
| Long-term intrathecal administration of midazolam and clonidine | Q39467069 | ||
| Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group | Q39474737 | ||
| Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design | Q39477114 | ||
| Antagonists of neuronal calcium channels: structure, function, and therapeutic implications | Q39479175 | ||
| Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo | Q39482050 | ||
| Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia | Q39508711 | ||
| Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial | Q39510239 | ||
| The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas | Q39523335 | ||
| Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood | Q39538457 | ||
| Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins | Q40643074 | ||
| Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. | Q41714742 | ||
| Prosaptide D5 reverses hyperalgesia: inhibition of calcium channels through a pertussis toxin-sensitive G-protein mechanism in the rat. | Q41715524 | ||
| Glutamate receptors in the mammalian central nervous system | Q41742131 | ||
| Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes | Q42557259 | ||
| Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice | Q42701449 | ||
| Peptide neurotoxins from fish-hunting cone snails | Q44887405 | ||
| Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. | Q45092798 | ||
| Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection. | Q46006101 | ||
| Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model | Q46153402 | ||
| Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy | Q46159568 | ||
| Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 | ||
| Effect of spinal cord stimulation on tactile hypersensitivity in mononeuropathic rats is potentiated by simultaneous GABA(B) and adenosine receptor activation | Q47876546 | ||
| Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. | Q47985419 | ||
| Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia | Q48400175 | ||
| Mexiletine for thalamic pain syndrome | Q48852796 | ||
| Effects of intrathecal vs. systemic clonidine in treating chronic allodynia-like response in spinally injured rats | Q48891106 | ||
| N of 1 randomised controlled trials of oral ketamine in patients with chronic pain. | Q51435608 | ||
| Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report. | Q51624005 | ||
| Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. | Q51634730 | ||
| Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat. | Q51644394 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropathic pain | Q2798704 |
| P304 | page(s) | 249-259 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Expert Opinion on Emerging Drugs | Q5421207 |
| P1476 | title | Emerging drugs for neuropathic pain | |
| P478 | volume | 6 |
| Q30384063 | Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain. |
| Q42874981 | Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pa |
| Q28249111 | Emerging adenosine receptor agonists |
Search more.